AlzChem Group AG (FRA: ACT)

Market Cap	647.21M
Revenue (ttm)	563.55M
Net Income (ttm)	50.10M
Shares Out	n/a
EPS (ttm)	4.93
PE Ratio	12.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 8, 2024

Volume	290
Average Volume	379
Open	64.40
Previous Close	64.60
Day's Range	63.60 - 64.40
52-Week Range	22.40 - 67.00
Beta	n/a
RSI	57.28
Earnings Date	Feb 28, 2025

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the...

• Industry: Chemicals and Allied Products
• Founded: 1908
• Employees: 1,708
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ACT

Financial Performance

In 2023, AlzChem Group AG's revenue was 545.79 million, a decrease of -0.68% compared to the previous year's 549.53 million. Earnings were 34.62 million, an increase of 15.20%.